C - Chemistry – Metallurgy – 08 – B
Patent
C - Chemistry, Metallurgy
08
B
C08B 37/06 (2006.01) A61K 31/00 (2006.01) A61K 31/715 (2006.01) A61K 31/732 (2006.01)
Patent
CA 2467451
Disease conditions which are dependent upon or moderated by angiogenesis are controlled by the use of a therapeutic material which interacts with cell surface galectins. Particular therapeutic materials comprise a polymeric backbone having side chains terminating in a sugar dependent therefrom. Disclosed are specific therapeutic materials in which the polymeric backbone is based upon polygalacturonic acid, and the side chains terminate in arabinose or galactose.
L'utilisation d'un matériau thérapeutique interagissant avec les galectines de surface cellulaire permet de lutter contre les états pathologiques dépendants de l'angiogenèse ou modérés par cette dernière. Certains matériaux thérapeutiques comprennent un squelette polymère possédant des chaînes latérales dépendantes de ce dernier et se terminant en un sucre. L'invention concerne des matériaux thérapeutiques particuliers, dont le squelette polymère est à base d'acide polygalacturonique, et dont les chaînes latérales se terminent en arabinose ou en galactose.
Chang Yan
Sasak Vodek
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Glycogenesys Inc.
LandOfFree
Method for controlling angiogenesis in animals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for controlling angiogenesis in animals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for controlling angiogenesis in animals will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1817762